Related Articles
LAPTM4B‑35 protein is a weak tumor‑associated antigen candidate
LAPTM4B‑35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma
LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion
LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma
The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review)